Jackson Hole Capital Partners’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$837K Hold
911
0.14% 122
2025
Q4
$979K Sell
911
-100
-10% -$95.6K 0.17% 110
2025
Q3
$771K Hold
1,011
0.13% 124
2025
Q2
$788K Sell
1,011
-45
-4% -$35K 0.14% 119
2025
Q1
$872K Sell
1,056
-215
-17% -$179K 0.17% 109
2024
Q4
$981K Hold
1,271
0.2% 99
2024
Q3
$1.13M Sell
1,271
-35
-3% -$31.5K 0.23% 93
2024
Q2
$1.18M Hold
1,306
0.26% 90
2024
Q1
$1.02M Hold
1,306
0.23% 97
2023
Q4
$761K Hold
1,306
0.19% 98
2023
Q3
$701K Buy
1,306
+3
+0.2% +$1.55K 0.21% 95
2023
Q2
$611K Sell
1,303
-48
-4% -$20.1K 0.17% 106
2023
Q1
$464K Buy
1,351
+4
+0.3% +$1.35K 0.12% 137
2022
Q4
$493K Buy
1,347
+3
+0.2% +$1.06K 0.15% 116
2022
Q3
$435K Buy
+1,344
New +$426K 0.13% 119

Other funds holding LLY

Jackson Hole Capital Partners's LLY Position: Q1 2026 in Review

Jackson Hole Capital Partners held its Eli Lilly (LLY) position steady in Q1 2026 at 911 shares worth $837K. The position accounts for 0.14% of the portfolio, ranked #122.

Jackson Hole Capital Partners first reported a position in LLY in Q3 2022 and has held it in 15 quarters since. The position peaked at $1.18M in Q2 2024. 4,354 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • Jackson Hole Capital Partners held 911 shares of Eli Lilly worth $837K as of Q1 2026.
  • Jackson Hole Capital Partners left its Eli Lilly share count unchanged in Q1 2026.
  • Eli Lilly made up 0.14% of Jackson Hole Capital Partners's portfolio in Q1 2026, its #122 holding.
  • Jackson Hole Capital Partners first reported a position in Eli Lilly in Q3 2022 and has held it in 15 quarters since.
  • Jackson Hole Capital Partners's Eli Lilly position peaked at $1.18M in Q2 2024.
  • 4,354 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Jackson Hole Capital Partners's 13F filing for Q1 2026, filed 8 May 2026.